Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples